Structural insights into the multifunctionality of rabies virus P3 protein.

NNS RNA virus liquid-liquid phase separation membrane-less organelles protein multifunctionality rabies lyssavirus

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
04 04 2023
Historique:
medline: 31 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: ppublish

Résumé

Viruses form extensive interfaces with host proteins to modulate the biology of the infected cell, frequently via multifunctional viral proteins. These proteins are conventionally considered as assemblies of independent functional modules, where the presence or absence of modules determines the overall composite phenotype. However, this model cannot account for functions observed in specific viral proteins. For example, rabies virus (RABV) P3 protein is a truncated form of the pathogenicity factor P protein, but displays a unique phenotype with functions not seen in longer isoforms, indicating that changes beyond the simple complement of functional modules define the functions of P3. Here, we report structural and cellular analyses of P3 derived from the pathogenic RABV strain Nishigahara (Nish) and an attenuated derivative strain (Ni-CE). We identify a network of intraprotomer interactions involving the globular C-terminal domain and intrinsically disordered regions (IDRs) of the N-terminal region that characterize the fully functional Nish P3 to fluctuate between open and closed states, whereas the defective Ni-CE P3 is predominantly open. This conformational difference appears to be due to the single mutation N226H in Ni-CE P3. We find that Nish P3, but not Ni-CE or N226H P3, undergoes liquid-liquid phase separation and this property correlates with the capacity of P3 to interact with different cellular membrane-less organelles, including those associated with immune evasion and pathogenesis. Our analyses propose that discrete functions of a critical multifunctional viral protein depend on the conformational arrangements of distant individual domains and IDRs, in addition to their independent functions.

Identifiants

pubmed: 36989298
doi: 10.1073/pnas.2217066120
pmc: PMC10083601
doi:

Substances chimiques

Viral Proteins 0
Virulence Factors 0
Protein Isoforms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2217066120

Références

Traffic. 2021 Dec;22(12):482-489
pubmed: 34622522
J Cell Sci. 2009 Oct 15;122(Pt 20):3652-62
pubmed: 19773364
Biophys J. 1999 Jun;76(6):2879-86
pubmed: 10354416
Mol Cell Proteomics. 2011 Jan;10(1):M110.002212
pubmed: 20736410
J Appl Crystallogr. 2021 Feb 01;54(Pt 1):343-355
pubmed: 33833657
Bioinformatics. 2011 Aug 1;27(15):2163-4
pubmed: 21666267
Nat Commun. 2017 May 19;8:15473
pubmed: 28524877
mBio. 2018 Sep 4;9(5):
pubmed: 30181255
J Virol. 2015 Feb;89(3):1939-43
pubmed: 25428867
Nucleic Acids Res. 2018 Jul 2;46(W1):W329-W337
pubmed: 29860432
Virus Res. 2007 Feb;123(2):154-60
pubmed: 17010466
mBio. 2020 Sep 22;11(5):
pubmed: 32963000
J Appl Crystallogr. 2017 Jun 26;50(Pt 4):1212-1225
pubmed: 28808438
Infect Disord Drug Targets. 2012 Feb;12(1):38-58
pubmed: 22034934
J Mol Biol. 2018 Nov 2;430(23):4773-4805
pubmed: 30017918
J Virol. 2019 Oct 15;93(21):
pubmed: 31375591
J Virol. 2000 Nov;74(21):10212-6
pubmed: 11024151
J Biol Chem. 2012 Aug 10;287(33):28112-21
pubmed: 22700958
J Mol Biol. 2019 Dec 6;431(24):4959-4977
pubmed: 31634467
J Virol. 2012 Sep;86(18):10194-9
pubmed: 22740405
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9112-7
pubmed: 10430904
J Vet Med Sci. 2016 Aug 1;78(7):1089-98
pubmed: 27041139
Biochemistry. 2007 Oct 30;46(43):12053-61
pubmed: 17924652
J Proteome Res. 2018 Apr 6;17(4):1474-1484
pubmed: 29558158
Oncogene. 2002 Nov 14;21(52):7957-70
pubmed: 12439746
IUCrJ. 2015 Feb 26;2(Pt 2):207-17
pubmed: 25866658
Cell Rep. 2019 Nov 12;29(7):1934-1945.e8
pubmed: 31722208
J Virol. 2010 Jul;84(13):6699-710
pubmed: 20427527
PLoS Pathog. 2022 Dec 8;18(12):e1011022
pubmed: 36480574
Traffic. 2023 Mar;24(3):146-157
pubmed: 36479968
Sci Rep. 2017 Oct 18;7(1):13453
pubmed: 29044157
Nat Methods. 2018 Mar;15(3):191-193
pubmed: 29377013
Cell Rep. 2022 Mar 8;38(10):110469
pubmed: 35263605
PLoS One. 2016 Mar 03;11(3):e0150477
pubmed: 26939125
J Virol. 2013 Sep;87(17):9486-500
pubmed: 23637410
J Virol. 2022 May 11;96(9):e0011122
pubmed: 35404083
Trends Microbiol. 2022 Dec;30(12):1217-1231
pubmed: 35902318
Mol Biol Cell. 2007 Aug;18(8):3204-13
pubmed: 17567954
Nat Commun. 2017 Jul 5;8(1):58
pubmed: 28680096
Bioinformatics. 2018 Jun 1;34(11):1944-1946
pubmed: 29300836
Sci Rep. 2016 Sep 21;6:33493
pubmed: 27649849
Nat Commun. 2018 Aug 3;9(1):3057
pubmed: 30076298
Acta Crystallogr D Struct Biol. 2016 Dec 1;72(Pt 12):1254-1266
pubmed: 27917826
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
J Appl Crystallogr. 2012 Mar 15;45(Pt 2):342-350
pubmed: 25484842
J Infect Dis. 2014 Jun 1;209(11):1744-53
pubmed: 24367042

Auteurs

Ashish Sethi (A)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Stephen M Rawlinson (SM)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Abhinav Dubey (A)

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.
Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.

Ching-Seng Ang (CS)

Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Yoon Hee Choi (YH)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Fei Yan (F)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Kazuma Okada (K)

Laboratory of Zoonotic Diseases, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193, Japan.

Ashley M Rozario (AM)

School of Chemistry, Monash University, Clayton, VIC 3800, Australia.

Aaron M Brice (AM)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.
Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Naoto Ito (N)

Laboratory of Zoonotic Diseases, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193, Japan.
Center for One Medicine Innovative Research, Institute for Advanced Study, Gifu University, Gifu 501-1193, Japan.

Nicholas A Williamson (NA)

Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Danny M Hatters (DM)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Toby D M Bell (TDM)

School of Chemistry, Monash University, Clayton, VIC 3800, Australia.

Haribabu Arthanari (H)

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115.
Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.

Gregory W Moseley (GW)

Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Paul R Gooley (PR)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, VIC 3010, Australia.
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH